BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Varelas C, Gavriilaki E, Sakellari I, Klonizakis P, Koravou E, Christodoulou I, Mavrikou I, Kourelis A, Chatzopoulou F, Chatzidimitriou D, Touloumenidou T, Papalexandri A, Anagnostopoulos A, Vlachaki E. Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center. JCM 2022;11:937. [DOI: 10.3390/jcm11040937] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Han J, Zhang X, Molokie RE, Njoku FU, Hussain FA, Farooqui M, Rizvi I, Saraf SL, Gordeuk VR. COVID-19 vaccination status and disease burden in patients with sickle cell disease. Br J Haematol 2022. [PMID: 36058234 DOI: 10.1111/bjh.18443] [Reference Citation Analysis]
2 Green NS, Van Doren L, Licursi M, Billings DD, Sandoval LA, Feit YMZ, Hod EA. Anti-SARS-CoV-19 antibodies in children and adults with sickle cell disease: A single-site analysis in New York City. Br J Haematol 2022. [PMID: 35759223 DOI: 10.1111/bjh.18294] [Reference Citation Analysis]